ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0001213.1|Nataxazole_1 # 1 # 69 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.667	BGC0001213.1|Nataxazole_1 	1	69	+	Loose	1000	20.7866	MCR-9.1	53.33	3004684	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GAGAAGGTGTTCGGCGGCTACATCGCCTACTTCGTGCGGGCCGGTGTGCTGCCGGCTCCGCAGGAGTGA	EKVFGGYIAYFVRAGVLPAPQE	MPVLFRVKVIPLVLLLAMIFAFLLNWPILLHFYEILSHLEHVKIGFVISIPFVLVAALNVVFMPFSVRFLLKPFFALLFITGSLVSYSTLKYKVMFDQTMIQNIIETNPQEAHSYLNGSIIIWFVFTGILPAILLFSIKIQYPEKWYKGIAYRLLSVLASLSLIAGVAALYYQDYASVGRNNSTLNKEIIPANYAYSTFQYVKDTYFTTKVPFQTLGNDAKRVVAHEKPTLMFLVIGETARSQNFSMNGYSRDTNAFTSKSGGVISFKNMHSCGTATAISVPCMFSNMNRTEYDSKKASNSENFLDIVQKTGVSLLWKENDGGCKGVCSRIPTVEIKPSDNPKLCDGKTCHDEVMLENLDDEIAKMPGDKLVAFHIIGSHGPTYYLRYPAEHRHFMPECARSDIENCTQEQLVNTYDNTLRYTDYVLAEMIEKLKNYSDQYNTVLLYVSDHGESLGESGLYLHGTPYKLAPDQQTHIPMQVWMSPGFIAGKHINMSCLENNAAKKSYSHDNLFSSILGLWDVSTSVYNPDRDLFRECRG	4.08	gnl|BL_ORD_ID|2245|hsp_num:0	3383			351	396	colistin A; colistin B
BGC0001213.1|Nataxazole_2 # 173 # 604 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.750	BGC0001213.1|Nataxazole_2 	173	604	-	Loose	390	33.8834	evgA	28.99	3000832	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGGCGCTGCCGCTGGCCGGGGAGGCCGCCGCCCAGGCCGCGCGGGCGTTCCGTGCCTCCGGGCAGCACCGCAAGGGCCGCGAGGCCCAGGCCGCCTGCCGGGAGCTGCTGCCCGGCTCCGGTGTGGCGCTGCCGCCGTGGGTGGAGGCGGACACCCGCCCCGAGCGGGACTCGGCCTCGCTCACGCCCCGGGAGCGGGAGGTCGCCGTACTGGCGGCGACCGGGATGTCCAACCGCGACATCGCGGACCGGCTGGTGGTGTCGGTGCGCACCGTGGAGAACCATCTGCACCGCATCTACCACAAGCTCGGCATCACCGCCCGCAACGACCTCCAGCGCGGCCTGGACAAGCTGATCGGCCGCCCGCGGGAGACCAACCGCATGGCACCGCTGCGGCTGTACGAGGGCGGTTCCGAGCACGTGGCGTAG	MGALPLAGEAAAQAARAFRASGQHRKGREAQAACRELLPGSGVALPPWVEADTRPERDSASLTPREREVAVLAATGMSNRDIADRLVVSVRTVENHLHRIYHKLGITARNDLQRGLDKLIGRPRETNRMAPLRLYEGGSEHVA	MNAIIIDDHPLAIAAIRNLLIKNDIEILAELTEGGSAVQRVETLKPDIVIIDVDIPGVNGIQVLETLRKRQYSGIIIIVSAKNDHFYGKHCADAGANGFVSKKEGMNNIIAAIEAAKNGYCYFPFSLNRFVGSLTSDQQKLDSLSKQEISVMRYILDGKDNNDIAEKMFISNKTVSTYKSRLMEKLECKSLMDLYTFAQRNKIG	70.10	gnl|BL_ORD_ID|936|hsp_num:0	1015			375	582	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0001213.1|Nataxazole_6 # 3344 # 5083 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.737	BGC0001213.1|Nataxazole_6 	3344	5083	-	Loose	1190	265.003	novA	34.8	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGATCCGTCGACTCCTGGAGGTGCTGGGGCCCGAGCACGCGCGCCCGGTGCGCCGGATGCTGGTCGCGCTGGTGACGGGCGCGGTGCTCCAGGGCATCGCCTTCGCCCTGCTGGTGCCCGTGCTGGAGGCGCTGTTCGGCTCCGACCCGGACGAGGTCTGGCCGTGGCTGTGGACGCTGGTCGCGGTGGCCGTGCTGTACTGCGCGGTCTACTACTGGAGCCTGCTGGCGGGCTTCGAGGCCGGTGCCGGCCTGGCCAGGAGCCTGCGCCAGCGGATCGGCGACCGGGTGGCCGAACTGCCGCTCGGCTGGTTCGCGCCGGAGCGGGTGGGCCAGCTCGGCCAGCTCACCACGAAGAGCGTGATGGACATCATGGGCGTACCGGCGCATCTGCTGCGGCCCCTGGTGACCAGCTTCGTGACGCCCGCGACCGTGACCGTGCTGATGTACCTGTTCGACTGGCGGCTCGCGCTGGCGGCCACGCTCACCGTGCCGGTCATCGTCCTGGTGTACCGGTGGAGCACCGCGCTGAGCCGGCAGGCCGACCGGGAGCGTACGGCGGCGCGGGCCGTGACCGGCGGCCGGGTGGTGGAGTTCGCGCAGCTCCAGCCGGTGCTGCGGGTGTTCGGCCGGGGCGAGGCCCGTTCGGGGGCCCGGCTCGGCGAGGCGCTGCGCACCCAGCGCGAGGCGTCGCGCCGGGTGCTGGTCACCGGGGTGCCCGGACTGATCGGCTTCAGCCTGGTGATCCAGGCCGCGTTCACCGCGGTCCTGCTGACCGGCACCTATCTGGCGCTGCACGGCGGTCTGGACGCGGCGAAGCTGCTGGCGCTGCTGGTCCTGGCGGTGCGGTTCACCGAGCCGATCGCCGAGACCGCGATCCTCGGTTCGACGCTCGGCACGGCGCGCTCCGCGCTGGCCCAGGTCGCCGACCTGCTGGCGCAGCCCACGCTGCCCGCGCCGGTCTCGCCGCGCGTGCCCGAGGGCAACCGGGTCGAGTTCGAGGACGTCACCTTCGGCTACGACGACGGCAGGCCGGTGCTCTCCGGGGTGTCGCTGACGCTGGCCGAGGGCACGATGACCGCGCTCGTCGGCCCGTCCGGCTCCGGCAAGACCACGGTGAGCAAGCTCGTCCCCCGGTTCTGGGACGTGGACGGCGGCGCGGTCCGGGTGGGCGGCGTGGACGTCCGGGAGATCGACCCGGAGGTGCTGATGTCGCGCGTCTCGGCGGTCTTCCAGGACGTGTACCTCTTCGAGGGCACCATCGCGGACAACATCCGGGTCGGGCGTCCCACGGCGACGGACGCGGAGGTCCGCGAGGCGGCCCGGCTCGCCCGGGTGGAGGAGATCGTGCACCGGCTGCCGGACGGCTGGGACGCCCGGGTCGGTGAGGGCGGCGCGCTGCTGTCCGGCGGGGAGCGGCAGCGGGTGTCGATCGCCCGCGCCATCCTGAAGAACGCGCCGATCGTGCTGCTCGACGAGGCGACCGCCTCGCTCGACCCGGAGAACGAGCAGGCGGTGCAGGACGCGCTGAGCGCGCTGACCGCCGGCCGCACCCTGCTGGTGATCGCCCACCGGCTGCGGACGGTCGCCGCCGCCGACCAGATCCTGTTCCTCGACGAGGGCCGGATCGTGGAACGCGGCACGCACGACGAACTCGTCACGGCGGACGGCCGGTACGCGTCGTTCTGGGCCCGGCGCAGCCGGGCACGCGACTGGAGTCTGGCCGGACAGAATTCTTGA	MIRRLLEVLGPEHARPVRRMLVALVTGAVLQGIAFALLVPVLEALFGSDPDEVWPWLWTLVAVAVLYCAVYYWSLLAGFEAGAGLARSLRQRIGDRVAELPLGWFAPERVGQLGQLTTKSVMDIMGVPAHLLRPLVTSFVTPATVTVLMYLFDWRLALAATLTVPVIVLVYRWSTALSRQADRERTAARAVTGGRVVEFAQLQPVLRVFGRGEARSGARLGEALRTQREASRRVLVTGVPGLIGFSLVIQAAFTAVLLTGTYLALHGGLDAAKLLALLVLAVRFTEPIAETAILGSTLGTARSALAQVADLLAQPTLPAPVSPRVPEGNRVEFEDVTFGYDDGRPVLSGVSLTLAEGTMTALVGPSGSGKTTVSKLVPRFWDVDGGAVRVGGVDVREIDPEVLMSRVSAVFQDVYLFEGTIADNIRVGRPTATDAEVREAARLARVEEIVHRLPDGWDARVGEGGALLSGGERQRVSIARAILKNAPIVLLDEATASLDPENEQAVQDALSALTAGRTLLVIAHRLRTVAAADQILFLDEGRIVERGTHDELVTADGRYASFWARRSRARDWSLAGQNS	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	94.15	gnl|BL_ORD_ID|1112|hsp_num:0	1210			249	1788	novobiocin
BGC0001213.1|Nataxazole_7 # 5083 # 6981 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0001213.1|Nataxazole_7 	5083	6981	-	Loose	1190	267.7	novA	34.48	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGGGCGGGTACAGTCGTCCCGGCGTTAGACAGCGTCTAACAGCCGTCCAATCGAAGCGCTTGGAGGCCCGCATGCCCGCGGGAAAGACCGCACTCGGCGCGATTCTCGGCCCGGTCAGGGGAAAGCTGCGCTGGGCGATCGCCGCCCAGGCCGTCTCGGCTGCCGCCGGCGTGGTGCCGTTCATCGCCGTCGCCGAACTGGGCCGGGTGCTGCTCGGCGACGGGGAGGACCGCACCGACCGCGCCTGGACGGTCACCGCGATCGGCGCGGGAGCGCTGCTGGTCCGGCTGATCGTCGCGCTCGTGGCCGGCGGGATCTCCCATCTCGCCGACAACGACCTTCAGTTCCACATCCGGCGCAGGCTCGTCGACCGGCTCGGCCGGGTGCCGCTCGGCTGGTTCTCGTCCCGCAACTCCGGCCAGGTCAAACAGGCCGTGCAGGACGACGTCGACGCGATGCACCATCTGATCGCCCACTCGCTGCTGGACATCACCACGGCCACGGTCGTCCCGGCCGCCTCCCTGGCGTATCTGTTCTGGGTGGACTGGCGGATGACCCTGGTGGTGATCGCGCCGCTGCTCATCGGTCTGACGCTGTACAGCGCCACCATGGCGGGCCTGGCGAAGAACCTGCCCGAGTACGACCGGGCGATGGGCCGCATCAACGGCAGCGCGGTGGAGTTCGTGCAGGGCATCGCCGTGGTGAAGACCTTCGGCCAGGCCCGCCGCGCGCACCGCGAGTTCAGCGAGGCCGCCGACGACTTCTCGGAGTTCTTCCTGAAGTGGGTGCGCTCCACCCAGTACTCCAAGGCGGCGGCCGAGATCGTGCTGTCCCCGATCGCGGTGCTGGTGGCCACCCTGGCGGGCGGTGCCCTCTTCGTGACGCGGGGCTGGCTCGACGCCGTGGACCTGCTGCCGTTCGCCCTGCTCGGCATCGGCCTGACCGCGCCGGTGCTGTCCCTGTTCTACGCCGGGTACGAACTGCGCGTGGCCCGCGGCGCGGCCGACCGGGTCGCGGGCATCCTGGACACCCCCGAACTCCCGGTGCCCGAGGCGCCCGGGAGCCCCGAGGGCGACCGGGTCGTCTACCGGGACGTGCGCTTCTCCTACGACGGCGAGCAGGACGCGCTGTCCGGGATCGATCTGGAGCTGGCGCCGGGCACCGTCACCGCGCTGGTCGGGCCCTCCGGTTCCGGCAAGAGCACCCTGGCGGCCCTGCTGCCCCGCTTCTGGGACGTCACCGGCGGCTCGGTCAGCGTCGGCGGCACCGACATCCGGGACATGGCCCTCGACGACCTCTACGGCCGGGTCGCGTTCGTCTTCCAGGACGTGCGCCTGAGCCAGGACACCATTGCGGCCAACATCCGCATGGGCCGCCCGGACGCCGGAGCGGACGAGGTCCGCGCCGCCGCCCGCGCGGCCTGCGTGGACGACGTCATCGAGGCGTTGCCGCGCGGCTACGACTCGGTGATCGGCGAGGACGCGCGGCTCTCCGGCGGCCAGGCGCAGCGGGTGTCCGTGGCGCGGGCGCTGCTCGCCGACGCCCCGGTGATCGTGCTGGACGAGGCCGCCGCGCACGCCGACCCGCACTCCGAGGCGGCCGTGCAGGACGCGCTGTCGGAGCTGACCCGGGGCCGGATCGTGCTGATGATCGCGCACCGGCTGTCCAGCGTCGTCGACGCCGACCAGATCGTGGTGCTGGACGAGGGCCGGATCGTCGAGCGCGGCCGGCACGCGGAACTGGTCGCGGCCGGCGGCCGCTACGCCCGGATGTGGCAGGCCCATGAACGTACGGCCCGCTGGCGCCCGCACGGACCGGGACCGGTGCCCCGGGACCCGGCCGCGGAGTCGGCGGCGGATGTCACGGCGGACGTCGCCGCGACCGGAGGAGTGAGCTGA	MGGYSRPGVRQRLTAVQSKRLEARMPAGKTALGAILGPVRGKLRWAIAAQAVSAAAGVVPFIAVAELGRVLLGDGEDRTDRAWTVTAIGAGALLVRLIVALVAGGISHLADNDLQFHIRRRLVDRLGRVPLGWFSSRNSGQVKQAVQDDVDAMHHLIAHSLLDITTATVVPAASLAYLFWVDWRMTLVVIAPLLIGLTLYSATMAGLAKNLPEYDRAMGRINGSAVEFVQGIAVVKTFGQARRAHREFSEAADDFSEFFLKWVRSTQYSKAAAEIVLSPIAVLVATLAGGALFVTRGWLDAVDLLPFALLGIGLTAPVLSLFYAGYELRVARGAADRVAGILDTPELPVPEAPGSPEGDRVVYRDVRFSYDGEQDALSGIDLELAPGTVTALVGPSGSGKSTLAALLPRFWDVTGGSVSVGGTDIRDMALDDLYGRVAFVFQDVRLSQDTIAANIRMGRPDAGADEVRAAARAACVDDVIEALPRGYDSVIGEDARLSGGQAQRVSVARALLADAPVIVLDEAAAHADPHSEAAVQDALSELTRGRIVLMIAHRLSSVVDADQIVVLDEGRIVERGRHAELVAAGGRYARMWQAHERTARWRPHGPGPVPRDPAAESAADVTADVAATGGVS	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	102.76	gnl|BL_ORD_ID|1112|hsp_num:0	1210			300	1773	novobiocin
BGC0001213.1|Nataxazole_8 # 7088 # 7810 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0001213.1|Nataxazole_8 	7088	7810	-	Loose	1900	32.7278	MexI	25.33	3000808	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAACCGGCTCAAGGCGGTACCGCCGCCGCCCGGCGCCCAGGCGTACTTCGGCGGTGAGACGGCGGTCTTCGACGACACGCTGGACGCGCTCGGCGAGACGCTGCCGTGGATGCTGCTGTACATCGCGGTGGCGACCTATCTGCTGCTGTTCCTGGCGTTCGGCTCGCTGCTGCTGCCGCTCAAGGCCATCGTCATGAACCTGCTGTCGCTGTCGGCCACCTTCGGTGTGCTGGTGTGGGTCTTCCAGGACGGCCATCTGGAGGGCCTGATCCGCTTCGACTCGACCGGCAACATCGAGCCGAACATGCCGATCATGCTGTTCGCGCTGATCTTCGGCCTCTCCATGGACTACGAGGTCTTCCTGGTCTCCCGCATCCGCGAGCAGTACGACCTGCTGGGCGACAGCACCGCCGCCGTGGCGTCCGGGCTCCAGAAGATCGGCCGGCTGATCGCGAACGCGGCGCTGCTGATGTGCGTGCCGCTCGCGGCGATCGCGACCAGCGGGGTGCTCACCATGAAGCTGTTCGGCGTCGGCATGGTGTTCGCGATCCTCGCCGACGTGGCGATCGTGCGCATCCTGCTCGTGCCCGCGGCGATGAAGCTGATGGGCCGGGCCGCCTGGTGGGCCCCCGGGCCGCTGGCCAGGTTCTACAGCAAGTACGGCATCAAGGAGTCCGACGAGGCTCCGGAGGTCAAGCGGCCGGTGCCGGTCGCGGGCTGA	MNRLKAVPPPPGAQAYFGGETAVFDDTLDALGETLPWMLLYIAVATYLLLFLAFGSLLLPLKAIVMNLLSLSATFGVLVWVFQDGHLEGLIRFDSTGNIEPNMPIMLFALIFGLSMDYEVFLVSRIREQYDLLGDSTAAVASGLQKIGRLIANAALLMCVPLAAIATSGVLTMKLFGVGMVFAILADVAIVRILLVPAAMKLMGRAAWWAPGPLARFYSKYGIKESDEAPEVKRPVPVAG	MTFTDLFVRRPVLALVVSTLILLLGLFSLGKLPIRQYPLLESSTITVTTEYPGASADLMQGFVTQPIAQAVSSVEGIDYLSSTSVQGRSVVTIRMLLNRDSTQAMTETMAKVNSVRYKLPERAYDSVIERSSGETTAVAYVGFSSKTLPIPALTDYLSRVVEPMFSSIDGVAKVQTFGGQRLAMRLWLDADRLAGRGLTASDVAEAIRRNNYQAAPGMVKGQYVLSNVRVNTDLTNVDDFREMVIRNDGNGLVRLRDVGTVELGAAATETSALMDGDPAVHLGLFPTPTGNPLVIVDGIRKLLPEIQKTLPPDVRVDLAYETSRFIQASIDEVVRTLVEALLIVVLVIYLCLGSLRSVLIPVATIPLSMLGAAALMLAFGFSVNLLTLLAMVLAIGLVVDDAIVVVENVHRHIEEGKSPVAAALIGAREVAGPVIAMTITLAAVYTPIGLMGGLTGALFREFALTLAGAVIVSGVVALTLSPVMSSLLLQAHQNEGRMGRAAEWFFGGLTRRYGQVLEFSLGHRWLTGGLALLVCISLPLLYSMPKRELAPTEDQAAVLTAIKAPQHANLDYVELFARKLDQVYTSIPETVSTWIINGTDGPAASFGGINLAAWEKRERDASAIQSELQGKVGDVEGSSIFAFQLAALPGSTGGLPVQMVLRSPQDYPVLYRTMEEIKQKARQSGLFVVVDSDLDYNNPVVQVRIDRAKANSLGIRMQDIGESLAVLVGENYVNRFGMEGRSYDVIPQSLRDQRFTPQALARQFVRTQDGNLVPLSTVVRVALQVEPNKLIQFDQQNAATLQAIPAPGVSMGQAVAFLDDVARGLPAGFSHDWQSDSRQYTQEGNTLVFAFLAALVVIYLVLAAQYESLADPLIILITVPLSICGALLPLALGYATMNIYTQIGLVTLIGLISKHGILMVEFANELQLHERLDRRAAILRAAQIRLRPVLMTTAAMVFGLVPLLFASGAGAASRFGLGVVIVSGMLVGTLFTLFVLPTVYTLLARNHAEVDKSPRSRQLAEADLLVNKA	23.32	gnl|BL_ORD_ID|4683|hsp_num:0	1647			930	1545	acriflavine; tetracycline; norfloxacin
BGC0001213.1|Nataxazole_9 # 7807 # 9426 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0001213.1|Nataxazole_9 	7807	9426	-	Loose	1900	38.1206	acrD	22.51	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGAAGTTTTTTCCAGTGAACCCGCAGGTCACAAGGGGTAACCCGGAGTCCTTCCGGTTAGACAGTGTGCAAGAGCCCTGGAAGGGGCATTCAAAACGCTGTTACGGTTGGCGCGGCGCCGGACCCTGGCAGGCCTGCGGCGCCCGCCTACTACCCCTAGGGAGAACCATGTTCGAGGCGCTGGGGCGATTCCTCTTCCGCAGGCGCAAACCGCTCCTTGTCCTGACGTTGCTGTTCGCCGTCCTGTCCGGTGCCTACGGCGTCGGCGTCTTCGGCGACATGAAACCCGGCGGGTTCGAGGACCCCGGATCCGACAGCCGCAAGGCGGCCCAGATCGCCGAGCGGGCGTTCCCGCAGCGGGCGCCGGACGCCCTGGTGGTCTACCGCGACAAGACCCGCACGGTCGACGACCCCGCCTTCCGGAAGTCGGTCACCGAGACGGTGCAGGCCCTGCCGAAGTCCTCGGTCAGCGGCTTCTCCACCTTCTGGATGACCAAGATGCCGGCGCAGGTCAGCCACGACCGGCACGCCACCTATGTGGCGATCAACCTCCAGGGCGCCGACGACAACGCCAAGGAGGTCTCGTACAAGGCGATCAAGGACAAGCTCGCGGCGCCGGGCCTGGAGACCCTGCGCGGCGGTCCGGTCCCCACGGGGCACCAGGCCAGTGACGAGATCGGCAAGGACCTCGGCCTGGCGGAGGGCCTGTCCTTCCCCATCCTCTTCATCCTGCTGGTGATCGTCTTCGGCGGTCTGGCCGCGGCCAGCCTCCCGCTGTTCGTCGGCGGTCTGTCCATCCTGGGCTCGATGGCGGTGCTGCGGGTCATCGCGCAGCTCACCGACGTGTCGGTGTTCGCGATGAGCCTGGTGACGATCCTCGGTCTCGCGGTCGCCATCGACTACGGGCTGCTGATCGTGAGCCGCTACCGCGAGGAGCTGGAGCGCGGCCACACCGGCGAGCAGGCGCTGTCCCGCACGGTCGCCACGGCCGGGCGCACGGTGGTGGTCTCCGGCACCACGGTCGCGGTGGCGCTGGCCGGCATGACGTTCTTCCCGTTCGGCTTCCTGAAGTCCATGGCCTACGGCGGTGTGGCCGCGGTCGTGCTGTCCGTCTTCTTCTCGCTGATCGCCCTGCCCGCGGTGCTGGGCGTGCTGGGCACCCGGGTCAACGCCCTGTCGCTGCGCCGGAACAAGGCGCCGCGCCAGGACGGCCAGGGCGGCTGGTACCGCCTGGCGCAGGGCCTGATGCGGCGTCCGGCGATCGTGGCGGTGGGCACGCTGGCCGTGCTGCTGGCGCTCGCGGTGCCCTTCACCCGGATCGAGTTCGGCGCCAACGACGCCCGCCAGCTGCCCAACAGCGCCGAGGGACGGCAGGTCGGCAACGCCCTGGACCGCGACTTCGACAGCGACGCCACCAAGTCCATCGACTCGCTGCTGGTGCTGAAGGGGGACGCCACCTCCCCCAGCAGGGTGCCGCGCTCAAGTCCTACACCGACCGGCTGGCCGCCACCAAGGGCGCGACCGGCGCGCAGATCAGCGGCGCCACCGGCACGAACGCGCGCATCTCGGTCACCTTCGACGGGCCCGCGGTCTCCACCCCGGCGCGCGACCTGGTGA	MKKFFPVNPQVTRGNPESFRLDSVQEPWKGHSKRCYGWRGAGPWQACGARLLPLGRTMFEALGRFLFRRRKPLLVLTLLFAVLSGAYGVGVFGDMKPGGFEDPGSDSRKAAQIAERAFPQRAPDALVVYRDKTRTVDDPAFRKSVTETVQALPKSSVSGFSTFWMTKMPAQVSHDRHATYVAINLQGADDNAKEVSYKAIKDKLAAPGLETLRGGPVPTGHQASDEIGKDLGLAEGLSFPILFILLVIVFGGLAAASLPLFVGGLSILGSMAVLRVIAQLTDVSVFAMSLVTILGLAVAIDYGLLIVSRYREELERGHTGEQALSRTVATAGRTVVVSGTTVAVALAGMTFFPFGFLKSMAYGGVAAVVLSVFFSLIALPAVLGVLGTRVNALSLRRNKAPRQDGQGGWYRLAQGLMRRPAIVAVGTLAVLLALAVPFTRIEFGANDARQLPNSAEGRQVGNALDRDFDSDATKSIDSLLVLKGDATSPSRVPRSSPTPTGWPPPRARPARRSAAPPARTRASRSPSTGPRSPPRRATW	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	51.98	gnl|BL_ORD_ID|1309|hsp_num:0	1427			1047	1569	
BGC0001213.1|Nataxazole_11 # 9794 # 10057 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=6bp;gc_cont=0.723	BGC0001213.1|Nataxazole_11 	9794	10057	-	Loose	1900	22.7126	acrD	24.29	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCAGGCCCGGCGGCTCGTTGCCGGACAGTTCCAGGGAGACCAGGCCGTGGGCGGTGGCCCAGCACGCCAGGGCCACGACCTCGGGTTCCAGCGCTTCGGTGAACTGCCCCGCCCGCTGTCCGCGGCGCACCGCGTCGACCAGCGGCTGGTACATCTCCAGCATCTCGCGCTGCCCCTCGGGGGCGGGCTCGAACTGGGCGAGGCTCTCCAGGAAGAGGATCGCGTACAGGTGCGGGTTCGCGAGCGCGTACGCGCGGTAG	MGRPGGSLPDSSRETRPWAVAQHARATTSGSSASVNCPARCPRRTASTSGWYISSISRCPSGAGSNWARLSRKRIAYRCGFASAYAR	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	8.39	gnl|BL_ORD_ID|1309|hsp_num:0	1427			2373	2583	
BGC0001213.1|Nataxazole_12 # 10390 # 11100 # -1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=5bp;gc_cont=0.769	BGC0001213.1|Nataxazole_12 	10390	11100	-	Loose	550	28.1054	OXA-308	28.57	3001763	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGACGACGGAGCTGTGGCTGCTGCCCGAGCCCGATGCGGCGTCCTTCGTCAGCGGGCTCGGCGGCGAGCGGCTGCTCGACGCGACGGAACGCGGCCGCCTGGCCCGGATGCTGACCCCGCGCCAGCGGGGCCACTTCCTGGCCGGGCGGCTGCTGTGCCGGCACGCGCTCAGCGAACGCACCGGGCATCCGGTCGACGGCTGGCGGTTCCCGGTGAACGCGTACGGGCGGCCCGAGCCGTGGCCCGAGCGGTACGGGGTGCGGTTCAGCATCTCGCACACCGACGGGCTCGTGGTCTGCGCCGTGACGGACGGACCGGCGTGCGGGGTGGACGTGGAGGGCCCGCTCTCCGCGGAGTCGGCGGCCCGCGTCGCCCGCTTCCTCGCCCCCTCCGAACAGGCGGAGCTGGCCGCCCTGCCCGCGGCGGAGCGGCCCGAGCGCACCCGGGAGCTCTGGGTGCTCAAGGAGGCGTACCTCAAGGGCCTGGGCACCGGCGTCCGCCGCGACCTCGACACCTTCACCTTCACCCCGCGCGGCACGGCTCCCCCGCGCGTGCGCGACCCCCTGCACGACACCACCTTCTCCTGGCACTTCAGCCTGTTCCGGCCCACCGCGGAGCACACCGTGGCCCTCGCCGTGGAGACGCCGGGACCCGAGCCGGCCCGGCTGCGGCTGCCGGGCGCGGCGGCCGTGACCGGGCCCGCCGCCTGA	MTTELWLLPEPDAASFVSGLGGERLLDATERGRLARMLTPRQRGHFLAGRLLCRHALSERTGHPVDGWRFPVNAYGRPEPWPERYGVRFSISHTDGLVVCAVTDGPACGVDVEGPLSAESAARVARFLAPSEQAELAALPAAERPERTRELWVLKEAYLKGLGTGVRRDLDTFTFTPRGTAPPRVRDPLHDTTFSWHFSLFRPTAEHTVALAVETPGPEPARLRLPGAAAVTGPAA	MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDGQHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMTLSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEAQFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQADGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL	84.59	gnl|BL_ORD_ID|2562|hsp_num:0	3470			537	696	cloxacillin; oxacillin; cefalotin
BGC0001213.1|Nataxazole_13 # 11097 # 12479 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.754	BGC0001213.1|Nataxazole_13 	11097	12479	-	Loose	525	28.1054	myrA	32.1	3001300	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	GTGACTTCCCTGCTCGATCCGCCCGCCGCGCACGCGGCGCAGACCAGCTGGCGCCGGCTGCCCGCCGGGCAGCAGCCGTCCTGGCCGGACGCCGCCGCGCTGGACGCGGCGGTCACCGCCCTCGCGTCGGCCCTGCCGCTGGTGACGGCCCGCGAGTGCGATCTGCTGCGGGCCCGGCTCGCCGCCGTCGCGCGCGGCGAGGCGTTCCTGGTCCAGGGCGGCGACTGCGCCGAGGAGCTGGACGCGGTGAACGCGGCGTCCATCGGCCGGACCGCCGGGACCCTCCAGCAACTGGCCGCCGTCCTCGGGTACGCGCGCTCGCTGCCCGTGGTGACGCTGGCCCGGATGGCCGGGCAGTACGCCAAGCCGCGTTCCTCGCCCACCGAGATCCGGGGCGGCGTGGAGCTGCCGGTGTACCGGGGCGACGCGGTCAACGGACACGCCTTCACGACCGCCGCCCGCACCCCCGACCCGCACCGGCTGGTGCGGGTCCACCACACCTCCGCCGCCACCTTGAACCTGGTCCGGGCGTACGGCGCCGGTGAGCACGCCGGGCCCGGCCAGGTGCTGGCGGCGCTGCGGGAGTTCACCGACGCCTCGCCCGAGCGGGACCGCTACGCGGCGCTCACCGCCGAGATCGAGCGGGCGGGCGGCTTCACCGGCACCGGTGACGGCTGGCACACGCCCGGCGAGCTGTTCATGTCGCACGAGGGGCTGCTGCTGGACTACGAGTCGGCGCTGGTGCGCCTGGACCCGGCCACCGGCGGGGCGTACGCCACCTCGGGGCACCTGCTGTGGATCGGGGAGCGCACGCGCCGCCTGGACGGGGCGCACGTGGAGTTCTTCTCCCGGATCAGCAACCCGGTCGCCGTCAAGATCGGGCCGTCCATCGAGACGGACGACCTGCTGCGCCTCATCGGCCGGCTGTCACCCGAGGGCGAGCCGGGCCGGCTCACGCTGGTGGTCCGGATGGGCGCCGGGAAGATCCGGGACGTGCTGCCGGGCCTGGTCGAGCGGGTCACCGCCGAGGGGCTGCCGGTGGCCTGGGTGTCGGACCCGATGCACGGCAACACCATCAGCGCGCCCAGCGGGCACAAGACCCGCCGGTTCGACGACGTGCTCGACGAACTGGCCGGGTTCTTCGAGGTGCTGACCGGTCTCGGCGCCCATCCCGGCGGTGTCCATCTGGAGCTGACCGGCGACGACGTGACGGAGTGCGTCGGCGGCGGCGACGGGATCGGCTTCGGTGATCTGCCCGCGCGCTACCGGTCGGTGTGCGACCCGCGGCTCAACCGCGGCCAGGCGCTGGACCTGGCCTACCGGCTCGCCGAACTCCTCGACACCGCCCGCCCGTCCTCCGGGGCGGTCCGGGAGAGCCGGTGA	MTSLLDPPAAHAAQTSWRRLPAGQQPSWPDAAALDAAVTALASALPLVTARECDLLRARLAAVARGEAFLVQGGDCAEELDAVNAASIGRTAGTLQQLAAVLGYARSLPVVTLARMAGQYAKPRSSPTEIRGGVELPVYRGDAVNGHAFTTAARTPDPHRLVRVHHTSAATLNLVRAYGAGEHAGPGQVLAALREFTDASPERDRYAALTAEIERAGGFTGTGDGWHTPGELFMSHEGLLLDYESALVRLDPATGGAYATSGHLLWIGERTRRLDGAHVEFFSRISNPVAVKIGPSIETDDLLRLIGRLSPEGEPGRLTLVVRMGAGKIRDVLPGLVERVTAEGLPVAWVSDPMHGNTISAPSGHKTRRFDDVLDELAGFFEVLTGLGAHPGGVHLELTGDDVTECVGGGDGIGFGDLPARYRSVCDPRLNRGQALDLAYRLAELLDTARPSSGAVRESR	MHPDLLPHLRCPVCGQPLHQADAAPPRALRCPAGHSFDIARQGYVNLLTGRAPHVGDTAEMIAAREEFLAAGHYDPFSAALATAAARAVPRRVRPGDGVGEPVAYPDLVVDAGAGTGRHLAAVLDAVPTAVGLALDVSKPALRRAARAHPRAGAAVCDTWGRLPLADATVAVLVNVFAPRNGPEFRRVLRPDGALLVVTPTAEHLVELVDRLGLLRVDPAKDARVADSLTRHFEPAGQSTHRHRLQLTRKEVLTLVGMGPSAWHTDPARLTARVAALSEPVTVTAAVRLARYRPI	155.93	gnl|BL_ORD_ID|137|hsp_num:0	158			639	870	tylosin; mycinamicin
BGC0001213.1|Nataxazole_14 # 12476 # 13030 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0001213.1|Nataxazole_14 	12476	13030	-	Loose	500	26.9498	CTX-M-72	36.36	3001933	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGGGCGCGCTGCAACTGCGCAGCCTGGGCTACGACGTGACGATCCGCCGCTACGACGAGCCGTACCGGCTCACCGGCCACGACCTGGTCCTGCTGGGCCCCGGTCCGGGCGACCCGCGCGAGGTGAACCACGCCAAGATCGCCCATCTGCGGGCGGTCACCGGCAGCCTCCTCAATCTGCGGATCCCGTTCGTCTCGGTGTGCCTGAGCCACCAGGTGCTCGCCTCGCTGCTCGGCCTGGAACTGCGCAGGCTGCACCGCCCGAACCAGGGGGTGCGGCGCACCATCGACCTGTTCGGCGCCGAGCAGCCGGTGTACTTCTACAACACGTTCGCCGCGTACAGCGACAGCGCGCTGCTGGACAGCCCGCACGCGCCCGGTCTGGTCGAGGTCGCCCGCGACCCGGCGAGCGGCGAGGTGCACGCGCTGCGCGGGCCGGGGTTCACCTCGGTGCAGTTCCATCCCGAGTCGGTGATGACCCTGCACGGCGCGGCCATCCTGGACGATCTGGTCACCGGTGCCCTCGCACCTCACCGAGCGGAGCTGACGGCGTGA	MGALQLRSLGYDVTIRRYDEPYRLTGHDLVLLGPGPGDPREVNHAKIAHLRAVTGSLLNLRIPFVSVCLSHQVLASLLGLELRRLHRPNQGVRRTIDLFGAEQPVYFYNTFAAYSDSALLDSPHAPGLVEVARDPASGEVHALRGPGFTSVQFHPESVMTLHGAAILDDLVTGALAPHRAELTA	MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDGTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL	63.23	gnl|BL_ORD_ID|1713|hsp_num:0	1855			477	594	
BGC0001213.1|Nataxazole_15 # 13821 # 14111 # 1 # ID=1_15;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.698	BGC0001213.1|Nataxazole_15 	13821	14111	+	Loose	1000	23.8682	MCR-4.6	37.93	3007231	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	TTGGCGATCACCTGGGAGGCGCTCTCCAGCGGGCTGCCGGTCACCGTCGGGGCCAGCAGCGTCTCGCGCAGGATCTCCCGCACGTCCCGGCCGCTGTGCCCGACGATGCGGTACTCGGTGTGGGCGAGGTGGGCCATCTCCTTCAGCAGCGGCCCGACCACGTGCGCGTCGTCGCACACGCGGCTCATCATCTTCAGTTCCTCGTCCAGCACCATGTACAGCTCGTTGGTCTCCTTGCCGTCGGCGAGGAAGTCCAGCACCGGGCCGACGTCCGGGCCGCCCGCCGGATAG	MAITWEALSSGLPVTVGASSVSRRISRTSRPLCPTMRYSVWARWAISFSSGPTTCASSHTRLIIFSSSSSTMYSSLVSLPSARKSSTGPTSGPPAG	MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALSFLFSIFTVKYLLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGLLPSYLIYKADIHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFVRNNSELRRYIVPTYFVSSASKYLNEHYLQTPMEYQQLGLDAKNASRNPNTKPNLLVFVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFNDTSSCGTATAVSLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLKSDPKLCSGQYCFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCSQEELINTYDNTILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVPMLAWVSNDFSQDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY	17.74	gnl|BL_ORD_ID|4851|hsp_num:0	5836			762	849	colistin A; colistin B
BGC0001213.1|Nataxazole_17 # 14773 # 15372 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.735	BGC0001213.1|Nataxazole_17 	14773	15372	-	Loose	550	24.6386	blaF	38.78	3003562	protein homolog model	n/a	n/a	penam	antibiotic inactivation	blaF family beta-lactamase	GTGCTGCTGGTGCACGACATGCAGCACTACTTCCTCGCCCCGTTCCGGCACGGCGCGCAGCCGCACACCGACCTGGTCGCGAACGTGGCCCTGCTGCGCGAGCGGTGCGCCGCCGCCGGCGTCCCGGTCGTCTACTCGGCGCAGCCCGGCGACATGACCCCCGCCCAGCGCGGTCTGCTGGCGGACTTCTGGGGCGCGGGCATGTCCGCGGACCCCGAGGACCGGGGCATCCCCGAGGTCCTGGCACCCGGCGAGCGGGACACCGTCCTGGTGAAGTGGCGGGCCAGCGCCTTCCACCGCACCCCGCTCCTCGAACTCCTGCGCGAGCAGGGCCGTGACCAGCTGATCATCTGCGGTGTCTACGCGCAGGTGGGCATCCTGCTGACCGCGTGCGACGCGTTCGCGCACGACATCCAGCCGTTCGTGGTCGCCGACGCGGTCGCCGACTTCACCCCGGACCGCCACCGGATGGCACTGGAGTACGCCGCCTCCCGGTGCGCCGTGGTGGCACAGACCGGGACGGTGCTGAGCGAGCTGGCGGCCCCGGCCGCCGCCTTCGCCGGCGAATTCGCGGGAGATCCCGTGGGAGGCCCCTCATGA	MLLVHDMQHYFLAPFRHGAQPHTDLVANVALLRERCAAAGVPVVYSAQPGDMTPAQRGLLADFWGAGMSADPEDRGIPEVLAPGERDTVLVKWRASAFHRTPLLELLREQGRDQLIICGVYAQVGILLTACDAFAHDIQPFVVADAVADFTPDRHRMALEYAASRCAVVAQTGTVLSELAAPAAAFAGEFAGDPVGGPS	MTGLSRRNVLIGSLVAAAAVGAGVGGAAPAFAAPIDDQLAELERRDNVLIGLYAANLQSGRRITHRLDEMFAMCSTFKGYAAARVLQMAEHGEISLDNRVFVDADALVPNSPVTEARAGAEMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPGDPRDTSTAAALAVGYRAILAGDALSPPQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGSGDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL	67.69	gnl|BL_ORD_ID|443|hsp_num:0	395			546	690	amoxicillin
BGC0001213.1|Nataxazole_18 # 15813 # 16637 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=8bp;gc_cont=0.759	BGC0001213.1|Nataxazole_18 	15813	16637	-	Loose	500	36.965	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	28.37	3003393	protein variant model	I194T	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGAGCGACACCCTCACGACAACAGGCACGACCGGCACGGCGGCCGCGGCGGGCGCCGAGTGGTCCGGCAGCGCGGTGGTCACCGGCGCGGCCGGCGGCATCGGCGCCGAGATAGCCCGCGCGCTGGCGGCGGCCGGTGTCCCGGTGGCGCTGCTGGACCGTGAGCCGGGGGCGCTGCGCGAGCTGGCGTCGGAGCTGAGCGCGGCCGGCGGCACGGTGCTGGCGGTGGCCGCCGATGTCACCGACAGCGCGGACGTGGACGCCGCCGTCGCCAAGGCGGAGGCCGAACTCGGTCCGGTCGCCTACCTGGTGAACGGCGCCGGGGTGCTGCACAGCGGCCCGGCCGGGGAGTTCTCCGACGAGGACTGGGACCACACGCTCGCGGTCAACGCGGGCGGGGTGTTCCGGGTGAGCCGGGCGGTGGCCCGGCTGATGGTCCCGCGCGGGCGCGGCTCGATCGTGACGATCGCCTCCAACGCGGCGCTCACCCCGCGCACGTCGATGGCGGCGTACGCGGCGTCCAAGGCCGCCTCGGCGATGTTCACCAAGTGCCTCGGTCTGGAGCTGGGGCGGCACGGCATCCGCTGCAACGTGGTGGCGCCCGGTTCGACGCGTACGTCGATGCTCACCGCCCTCCAGGGCGACGCGGCCGTGCGCGCCTCGGTGGACGGGGTGCCCGACGCGTACCGGGTCGGTATCCCGCTGGGCCGGATCGCCGAGCCCGCGCACATCGCCGACGCGGTGCTGTTCCTGCTGTCCGACCGGTCCGCGCACATCACGCTCCAGGACCTGACCGTGGACGGCGGCGCGGCCCTGGGCGTCTGA	MSDTLTTTGTTGTAAAAGAEWSGSAVVTGAAGGIGAEIARALAAAGVPVALLDREPGALRELASELSAAGGTVLAVAADVTDSADVDAAVAKAEAELGPVAYLVNGAGVLHSGPAGEFSDEDWDHTLAVNAGGVFRVSRAVARLMVPRGRGSIVTIASNAALTPRTSMAAYAASKAASAMFTKCLGLELGRHGIRCNVVAPGSTRTSMLTALQGDAAVRASVDGVPDAYRVGIPLGRIAEPAHIADAVLFLLSDRSAHITLQDLTVDGGAALGV	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	101.86	gnl|BL_ORD_ID|1964|hsp_num:0	1574			387	792	isoniazid
BGC0001213.1|Nataxazole_19 # 16634 # 18118 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=7bp;gc_cont=0.737	BGC0001213.1|Nataxazole_19 	16634	18118	-	Loose	750	26.9498	LRA-10	24.37	3002489	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase	ATGGGGGCCCGGCTGATCACCGGCGGCACCGTCTACACCGCCGACGCCCAGGAGTCCGTGCACGCCCGCGGCGCGGTGCTGACCGTGGACGACAAGGTCGTCGCGGTGGGCCCGGCCGTCGAGGTGGAGCAGGCCGTCCAGGCGCTGGACCCGGCCGTGCGCGCGGAGCTGCGCCGCCTGGACGCGAGCCGGATGATGGTGCTGCCCGGCTTCGTGAACGCCCACTGGCACGAGATGTTCGCGATGGGCTTCACCATGCGCGGCGCGCTGCGCCCGCCCTCCGACCGCGCCGACCAGGTCGCGTTCATGGGCGGCGGCGGTGACATGCACCAGATCTCCGCCACCTTCGACCGGTTCGACGGCCTCATCGAGGCGATGACCGAGGACGAGGCGCGGGCCATCGCCGAGTACTCGATGTGGATCCAGTTGCGCGGCGGTGTCACGACGCTCGGCGACATGGGCTCGCTCAACCGGCCGCTGGCCATGGTGGAGGCGGCGCGCCGCCTCGGGATGCGCTTCTCGGCGTCCACCTGGGCGAGCGACGCGGTGCTGGCGCCGGACCGGTCGCGGTTCCTGCGCACCCGGGACGCGGACACGGTGCTCGCCTCCTTCGAGGCGCTGCTCGGTGCGGTCGCCGCCGACCCCACGGGCCGCATCCGGTGCCGCCCGAACGTCTCGTACGTCACCAACATGACGGACGAGCTGGCGCGCGGCATGGCCGAACTCGTCGAGCGGCACGATCTGCCGTTCGCCACGCATGTGGGCGCGCTGCGCAACGAGGCCGACGCGATGCGCGCCTACCACGGGGAGACCGGGGTGCGCCGGCTGGCGGAGGCGGGTCTGGTCGACGAGCGGCTGATGGCCGGGCACAGCGCCTTCCTGGACGACCAGGAGCAGAAGCTGATGCTCGCCGGGCGGGCGCACATCTCCCACTCCCCCGGCAAGTACGGCCCGTCGGGCGAGTCCGCGCTCACCGAGACCGGTGTGGTCCCGGCGCTGCGCCGGGCCGGGCTGGACGTGTCGCTGTCGACCGACGCGGCGGCGCTGCCGGGCGCGGGCATCGCCGAGACGATGCGCGCGGCCTGGCAGATGTACAACGAGATGAGCGCCGACCAGACCGAGGTGCTGCCCACCGACGCGCTGGCGATGGCCACCCGGATCGCGGCGAAGGGCCTGCGCTGGGACGACGCGGTCGGCAGCCTGGAGCCCGGCAAGCAGGCCGACCTGCTGCTGGTGCGCACGGACGACTGGCGCTATCTGCTCAACCCGCGGCCGCTGGAGAGCTTCCTGTGGCTCGCCGGTTCGGCGGACGTGGACACGGTGATCGTCGGCGGCCGGACCCTCGTGGAGGGCGGCCGGGGCGTGGAGGTCGACGAGGCGGCGCTGCGCGACCGCTACCTCCAGGCACTGCGCGGTTTCACCACCCGCGCCCTGCGCGTTCCCGCGGAAGCGGTCGACCCGGTACTGGCGGAGGTGGCCCGATGA	MGARLITGGTVYTADAQESVHARGAVLTVDDKVVAVGPAVEVEQAVQALDPAVRAELRRLDASRMMVLPGFVNAHWHEMFAMGFTMRGALRPPSDRADQVAFMGGGGDMHQISATFDRFDGLIEAMTEDEARAIAEYSMWIQLRGGVTTLGDMGSLNRPLAMVEAARRLGMRFSASTWASDAVLAPDRSRFLRTRDADTVLASFEALLGAVAADPTGRIRCRPNVSYVTNMTDELARGMAELVERHDLPFATHVGALRNEADAMRAYHGETGVRRLAEAGLVDERLMAGHSAFLDDQEQKLMLAGRAHISHSPGKYGPSGESALTETGVVPALRRAGLDVSLSTDAAALPGAGIAETMRAAWQMYNEMSADQTEVLPTDALAMATRIAAKGLRWDDAVGSLEPGKQADLLLVRTDDWRYLLNPRPLESFLWLAGSADVDTVIVGGRTLVEGGRGVEVDEAALRDRYLQALRGFTTRALRVPAEAVDPVLAEVAR	MAIAILSSCFAPLASRAADDSARIRAIVDQAIRPVMAEHDVPGMAVAVTVDGQPFVFNYGVASRESNTPVSDATLFELGSISKTFAATLASYAQVTGKLSLDDHPGKYMPQLKGSAIDKATLLNLGTYTAGGLPLQFPDDVSDQQMASYFQHWKPKAAPGVQRTYSNPSLGLFGHLTSLALKSRFTDALETNVLTQMGMKSTYVHVPQSAMANYAWGYDQANKPGRMNPGVLADGIYGIRSTAADMIRYVQANIAPGKLETPLRRAVEGTHVGYFKVGGMVQGLGWEQYPYPVSLQQLQAGNSTTMAWEANPAQKLTPPSVPSGATLFNKTGSTSRFGAYVAFVPEKKIGIVILANKNIPGPDRIKAAHAILEQL	131.73	gnl|BL_ORD_ID|1915|hsp_num:0	2119			12	330	
BGC0001213.1|Nataxazole_20 # 18118 # 18342 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.738	BGC0001213.1|Nataxazole_20 	18118	18342	-	Loose	550	23.0978	OXA-155	38.46	3001460	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGCGCCCGTACTGGGCCTCGCACCGGAGCGGATCGAGCCGGACGCCAGTCTGGTGCTGCTCGGGCTCAGCTCGCTGGAGATCATGCGGCTGGTCAGTCGCTGGCGCAAGGCGGGTGTCCCGGTGCAGTTCGAGGCGCTGGTCGCGGCGCCGACCCTGAGCGGCTGGCTGGCCCACTTCGACTCGCTGCGCACCTCCGCGCCGACCGCGCCCGGAGCGGCGTGA	MAPVLGLAPERIEPDASLVLLGLSSLEIMRLVSRWRKAGVPVQFEALVAAPTLSGWLAHFDSLRTSAPTAPGAA	MKRILSRWRRAAVVLRLASAVVAHGLLPSPAHALELSRASAAAAPSVAAPVHVTERADWGKFFAAENVKGTVVVLDGKTQTYQAYDSARAERRMSPASTYKIFNSLLALESGALDNERETIPWDGKPRRIKAWNAELNLRDAFRVSCYPCYQVVSHKIPRAYAQAKLDAVGYGNRTIGRVNDTYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANADYVLHGKTGWFVEKKPDIGWWVGWLERDGNLTMIALNIDMNGDADGPKRARIVREVLKNLKLI	25.34	gnl|BL_ORD_ID|2560|hsp_num:0	3419			0	78	cloxacillin; oxacillin; cefalotin
BGC0001213.1|Nataxazole_21 # 18389 # 20008 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0001213.1|Nataxazole_21 	18389	20008	-	Loose	1000	60.8474	almE	21.41	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCTTGAGGGTTGCGTCCCCTGGCCCGAGGACATCGCGGCGCGCTACCGCGAGCAGGGCATCTGGCGCGGTGACACGCTCGGCACGGTGCTGCGCGAGGCCGCCCGCCGGTACGGCGAGCGGACCGCGCTGGTGCACGGCGAACGCCGGATCAGCTACGCCGAACTCGACCGCTGGGCCGACCGGCTGGCCGCCGGGTTCGCCGCGCACGGGCTGAAGGCCGGCGACCGGATCGTGGTGCAGCTGCCCAACGTGCCCGAGTTCGTGGCGATCGCCTTCGGGCTGACCCGGCTCGGCGCCAAGCTGGTCTTCTCGCTGCCCGCGCACCGGGCCACCGAACTGGTCCACCTGGTCGAGCTGAGCGGCGCCGTGGGCTTCCTGGTGCCCGAGTCGCACCGCGGCCACGACCACCGCGAGCTGGCCCGGCAGGTGAAGGCGGAGACCACCACCCTGGAGACGCTCTTCGTGCTGGGCGCCAAGACCGAGGGGTTCGTCTCGGTCGCCGAGCTGGAGACGGCGGTCCCCGACCCGCGGCCGCTGCCCGAACCCGACGCGTCGGACGTGGCGTTCTTCCTGCTGTCGGGCGGGACCACGGCCCTGCCGAAGCTGATCCCGCGCACCCACGACGACTATGTGTACATGTCGGGCCGGGCCGCGGCGGTGTGCGAGCTGGCCGAGGACGACGTGTATCTGGCCGTGCTGCCCATCGAGTTCAACTTCGCCTTCGGCTGCCCCGGTCTGCTCGGCACGTTCCTGACCGGGGGCACCGCCGTCCTCGCCGACACGCCCAACCCGCTGGACTGCTTCCCGCTGATCGAGAAGCACGGCGTCACCGTCACCGCGATGGTGCCGTCCATCATGACGCTGTGGCTGGAGGCGGCCGAGTGGTCCGGGGAGGACCTGTCGACGCTGCGGCTGGTGCAGGTCGGCGGGGCCCGGATGACCCGCGAGTTCACCGAGCGCATCCAGCCCGTGCTGGGCGCCCGGCTCCAGCAGGTGTTCGGCATGGCCGAGGGCCTGCTCACCTTCAGCCGCCCCGACGACCCGGCCGACGCGGTGCTCACCACGCAGGGCCGGCCGGTCTCCGACGCCGACGAGATGCTCATCCTCGGCGAGGACGGCACCCCGCTGCCGCCCGGCGGCATCGGCGAGCTGGTCACCCGCGGCCCGTACACGCTGCGCGGCTACTACCGGGTGCCCGAGTACAACCGGCGGGCCTTCACCCCGGACGGCTTCTTCCGCACCGGTGACCTGGCCCGGCTCACCGAGGACGGCGACCTGGTCATCGAGGGCCGGATCAAGGAGACCATCATCCGCGGCGGTGACAAGATCGCCGCCGGTGAGGTCGAGGACCTGCTGCTCACCCACCCGGACATCGCGGCGGCGGCCGTCATCGGCGTACCGGACGAGTTCCTGGGCGAGCGGATCTGCGCGTTCCTGGTGGCCGCGGGCCCCGAGGTCTCCCTCGCCGACCTCAAGCAGGCCGTGCACGCACGGGGCGTGGCCGACTACAAGCTGCCCGATCTCGTGCACTACCTGCCCGAACTCCCCCTGACCCCGCTCGGCAAGGTCGACAAGAAGGCGCTGGCCCGACATGCCGCGTCCGAGCAGGAAGGCTGA	MLEGCVPWPEDIAARYREQGIWRGDTLGTVLREAARRYGERTALVHGERRISYAELDRWADRLAAGFAAHGLKAGDRIVVQLPNVPEFVAIAFGLTRLGAKLVFSLPAHRATELVHLVELSGAVGFLVPESHRGHDHRELARQVKAETTTLETLFVLGAKTEGFVSVAELETAVPDPRPLPEPDASDVAFFLLSGGTTALPKLIPRTHDDYVYMSGRAAAVCELAEDDVYLAVLPIEFNFAFGCPGLLGTFLTGGTAVLADTPNPLDCFPLIEKHGVTVTAMVPSIMTLWLEAAEWSGEDLSTLRLVQVGGARMTREFTERIQPVLGARLQQVFGMAEGLLTFSRPDDPADAVLTTQGRPVSDADEMLILGEDGTPLPPGGIGELVTRGPYTLRGYYRVPEYNRRAFTPDGFFRTGDLARLTEDGDLVIEGRIKETIIRGGDKIAAGEVEDLLLTHPDIAAAAVIGVPDEFLGERICAFLVAAGPEVSLADLKQAVHARGVADYKLPDLVHYLPELPLTPLGKVDKKALARHAASEQEG	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	96.94	gnl|BL_ORD_ID|4935|hsp_num:0	5928			573	1650	colistin A; colistin B
BGC0001213.1|Nataxazole_23 # 21649 # 22959 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.728	BGC0001213.1|Nataxazole_23 	21649	22959	+	Loose	725	26.1794	SRT-1	30.77	3002493	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	SRT beta-lactamase	ATGTCGCGCTCGCGTCCGGAACTTGGTGACTGGTCGAGCCCGGCCGAACTGGCCGAGCTCCAGCGGTCCCAGCTGCCGAGGGTCCTCGCGCAGGCACTCCGTTCGCCGTTCTACGCGGCCCGCTACCGCGGCACCACACCGCCGCGCACCGCGGACGACTTCGCCGGCGTCGAGGTGACCGCCAAGCAGGACCTGCGCGACCAGTACCCCTTCGGGATGCTCGCGGTCGGGCGCGAACACCTGGCCACCTACCACGAGTCCAGCGGCACCGCGGGCGAACCCACCGCCTCCTACTACACGGAGGAGGACTGGACCGACCTCGCCGAGCGCTTCGCCCGCAAGTGGACCGGCATCCACCCCTCCGACACCTTCCTGGTGCGCACCCCCTACGGCCTGGTCATCACCGGCCACCTCGCCCAGGCCGCGGGACGGCTGCGCGGTGCGACCGTCGTCCCCGGCGACGCCCGCTCGCTGGCCACCCCGCTCTCCCGCATGGTGCGCGTCCTGAAGACCCTCGACGTGACGCTCACCTGGTGCAACCCGACCGAGATCACCATGCTGGCCGCCGCCGCCAAGGCCGCCGGACTCCGCCCCGACCAGGACTTCCCGCACCTGCGGGCCATGTTCACCGCCGCCGAGCCGCTGACCGAGGTGCGGCGCCGCCGGCTCAGCGAGATCTGGGGCGGCATCCCGGTCGTCGAGGAGTACGGCTCCACGGAGACCGGCACCATCGCCGGGCAGTGCCCCGAGGGCCGGATGCACCTGTGGGCGGACCGGGCGATCTTCGAGGTGTACGACCCGAGGACCGGCACGCTCTCCGAGGCGGGCCGCGGCCAGATGGTCGTCACCCCGCTGTACCGGGACGCGATGCCGCTGCTGCGCTACAACCTCGCCGACGACGTCGAGGTGTCCACCGACCCGTGCGGCTGCGGCTGGCTGCTGCCCACGGTCACCGTGCTGGGGCGGGCCGGAACCGGTCACCGGATCGGTCCGGCGACCGTCACCCAGCAGCGGCTGGAGGAGCTGGTGTTCTCCCTGCCGGCCGCGTACGAGGTGATGTTCTGGCGGGCCAAGGCCCACCCGGACGTGCTGGAGCTGGAGTTCGAGGCGCCCGAGCCGGTGCGGCAGCGGGCCGTCAAGGAGCTCGGCGCCGCGCTCGACCGCGAACTGGGGGTCCCGCACCGCATCACCGGCCTCGCCCCGGGCACCCTCGTCCCGGCGGAGGCCCTCACCGCCCAGCGCGACATCCTCAAGGCCCGCTACCTCTTCGCGGAGGACGAGGACTGGGACAAGGCGGTCATGTACTTCTGA	MSRSRPELGDWSSPAELAELQRSQLPRVLAQALRSPFYAARYRGTTPPRTADDFAGVEVTAKQDLRDQYPFGMLAVGREHLATYHESSGTAGEPTASYYTEEDWTDLAERFARKWTGIHPSDTFLVRTPYGLVITGHLAQAAGRLRGATVVPGDARSLATPLSRMVRVLKTLDVTLTWCNPTEITMLAAAAKAAGLRPDQDFPHLRAMFTAAEPLTEVRRRRLSEIWGGIPVVEEYGSTETGTIAGQCPEGRMHLWADRAIFEVYDPRTGTLSEAGRGQMVVTPLYRDAMPLLRYNLADDVEVSTDPCGCGWLLPTVTVLGRAGTGHRIGPATVTQQRLEELVFSLPAAYEVMFWRAKAHPDVLELEFEAPEPVRQRAVKELGAALDRELGVPHRITGLAPGTLVPAEALTAQRDILKARYLFAEDEDWDKAVMYF	MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGVASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGVSLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIVMLGMIAAKSLDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAKSYGIKSNARDLIRYLDANLQQVKVAHAWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFPNDDRVEAAYHIVQALEKR	115.34	gnl|BL_ORD_ID|181|hsp_num:0	199			384	531	
BGC0001213.1|Nataxazole_25 # 29129 # 29917 # -1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.716	BGC0001213.1|Nataxazole_25 	29129	29917	-	Loose	390	33.113	MexZ	27.69	3003709	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCTAATAGGTTAGTGTTGACCATGCCTTGCGAGCCGCCTGGCATCCCAGCGCTGACGGAACAGCGCCCCAGTGTGAGGTCTTTCGTCATGTCAGACTCAGCTCCCCGCCGCCGCTCCCGGGCGTCGGCGGGTCTGCCGCCGATCACGGCAGAGAAGATCATCGACGCCGCGGTCGAACTGACCGGGGAACGCGGGCTCGACGGCTGGTCCATCCGGCAGATCGCCACGCGCCTCGACGTCTGGCCGGGGGTGATCGCCCACCACGTCGGGGACCGCGAGGCGGTGGTCATGGGCGTGACCGACCGCGTCATCTCCCGCATACCCGTGCCCGACGACGACGTCCCCTGGCGGGACTGGTTCCGCTCCGTGATGTCGGAGGGCCGCACCGTGCTGCGCGAGTTCCCGGGCGTGGCCCGGCGGCTGTGCGTCGTCGGCCCGAACGTGCCGGCCGCGCTCCCCACCATCGACACGGGCATCCGGGTCCTGCTGAAGGCCGGGTTCGGCGCGCACGCGCCCGAGGTCTACCGCTACCTGTTCAACTGCGCGTTCACGCTGGTCGCGGTCGAGGACGACCGGGGCAGCTTCCCCACGGCACGCGCCGAGATGGGGCGCGCGATGGCCGCCTTCGCCGAGGACGAGACGCATCCGGGCCTCGCCGCGGCCGGTACCACGGCCCGCTCCCGCAGCACCGACCCCGCGGCCGTCGCCGCGCAGGAGACGGAGTTCTTCCGCTTCACGGTCGAACGCTCCCTGGACGGCGCGGAAGCCATGCTGACGTCCCGCTGA	VANRLVLTMPCEPPGIPALTEQRPSVRSFVMSDSAPRRRSRASAGLPPITAEKIIDAAVELTGERGLDGWSIRQIATRLDVWPGVIAHHVGDREAVVMGVTDRVISRIPVPDDDVPWRDWFRSVMSEGRTVLREFPGVARRLCVVGPNVPAALPTIDTGIRVLLKAGFGAHAPEVYRYLFNCAFTLVAVEDDRGSFPTARAEMGRAMAAFAEDETHPGLAAAGTTARSRSTDPAAVAAQETEFFRFTVERSLDGAEAMLTSR	MARKTKEESQKTRDGILDAAERVFLEKGVGTTAMADLADAAGVSRGAVYGHYKNKIEVCLAMCDRAFGQIEVPDENARVPALDILLRAGMGFLRQCCEPGSVQRVLEILYLKCERSDENEPLLRRRELLEKQGQRFGLRQIRRAVERGELPARLDVELASIYLQSLWDGICGTLAWTERLRDDPWNRAERMFRAGLDSLRSSPYLLLADA	124.76	gnl|BL_ORD_ID|4693|hsp_num:0	2223			33	228	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; meropenem; chloramphenicol; arbekacin; norfloxacin; ofloxacin; gentamicin
BGC0001213.1|Nataxazole_26 # 30147 # 31694 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=10bp;gc_cont=0.733	BGC0001213.1|Nataxazole_26 	30147	31694	+	Loose	600	165.236	Acinetobacter baumannii AmvA	29.58	3004577	protein homolog model	n/a	n/a	macrolide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGCAAATGGATGCCGCTGCTGGCCGTGTGCCTGGGCACCTTCATGCTGCTCATCGACGTGACCATCGTGAGCGTCGCCCTGCCCCAGATGACCGACTCGCTGGACACCTCCTTCTCCGCCCTCCAGTGGGTCGTCGATGTCTACGTCCTCGTCCTCGCCGCCCTGCTGATGGCGCTCGGCTCGCTGTCCGACCTGGTCGGCGACCGGCGGGTCTACCTCGCCGGACTGACCGTCTTCGCCCTCTCCTCGCTCGCCTGCGGCCTGGCCACCAGCAGCGAGGCGCTGATCGCCGCGCGCGGTGTGCAGGGCCTGGGCGCCGCCGCCATGTTCGCCACCAACACCGCGCTCATCGCGCGCAACTACGAAGGCCGCGACCGCGGTATCGCGTTCGGCATGTGGGGCGCGGTCAACGGCGCCGCCGCGGCGGCCGGACCGATCCTGGGCGGCATCCTCACCGAGCACCTCAACTGGCGCTGGATCTTCCTGGTCAACCTGCCCGTGGCCGCCGTCGCCCTCTACATCGGCGCCCGCTTCCTGGCCGGCTCGGAGACCCGGACCGACCGCCGCGTCGACCTGCCCGGCACCGTCGGCTTCACCCTCGTCGCCACGCTGCTGATCTTCGCCCTGATCCGCGCGGGCGAGGACGGCTGGGGCGCCGGCAACACCCTGGCGCTGTTCGGCGGTTCGGCGCTCGCGCTGGTCGTCTTCCTGCTGGTCGAACGCGGGCGGCGGGACCCCATGCTCGACCTCGGGCTGATGCGTACGCCGTCCTTCGCCACCCTGATGGCCGGTGCCGTCATCTTCAGCGCCGCCGCCTTCGCCAACCTGGTGTTCGTGTCGGTGTGGGCCCAGTCGGTGCTCGGCTTCAGCCCGGTCAAGGCCGGACTGATCCTCATGCCGTTCAGCGGTGTGTCCTTCCTCGCCGCAGGACTGGGCGGCCGGTTCCTGGCGAACGTGCCGCCGCAGTTCCCGATCGGCGGCGGACTGCTGCTGATCGGCGCCGGTTCGTTCCTGGAGATGTTCGTCTCCGGCACCTCCGGCTGGACCGGGCTGCTGGCCGGCTTCCTGGTGGCCGGTGTCGGCGTCGGCATCGCCTCGCCCATCCTCGCCTCGGCCGCGCTGGCGGCGGCGCCACCGGACCGCGCGGGCATGGCGGGCGGCGCGGCCAACACCTTCCGACAGCTCGGCTTCGCGCTGGGCATCCCGGCCGTCGGCACCATCCTGTCCGGCGCCGTGGCGGCCAAGCTGACGGACAGCAAGCTGTTCGCCGACGCCGACGCCGCGGCCGAGCTCGTCACCGGCGGGCAGTCCGGCGCCGTGCTCGGCGCGCTCCCCGCGCAGTCCCGCGCGGCGGCGCAGCGCGTGGTGGAGGACGCCTACGCGGCGGGTCTCGACCGGGTCTTCCTGCTCGGCGGTCTGGTGGCCGTCGTCGCCGGCGCCCTGGTGCTGCTCCTGGTGCGCGGTGCCGCGACTCCCGCCCCGGGCGGGGACCGTCCGGGCGCCCCCGGGGTCAAGGCGTCGGAGGAGGGCGTTCCCGCGGTGTGA	MRKWMPLLAVCLGTFMLLIDVTIVSVALPQMTDSLDTSFSALQWVVDVYVLVLAALLMALGSLSDLVGDRRVYLAGLTVFALSSLACGLATSSEALIAARGVQGLGAAAMFATNTALIARNYEGRDRGIAFGMWGAVNGAAAAAGPILGGILTEHLNWRWIFLVNLPVAAVALYIGARFLAGSETRTDRRVDLPGTVGFTLVATLLIFALIRAGEDGWGAGNTLALFGGSALALVVFLLVERGRRDPMLDLGLMRTPSFATLMAGAVIFSAAAFANLVFVSVWAQSVLGFSPVKAGLILMPFSGVSFLAAGLGGRFLANVPPQFPIGGGLLLIGAGSFLEMFVSGTSGWTGLLAGFLVAGVGVGIASPILASAALAAAPPDRAGMAGGAANTFRQLGFALGIPAVGTILSGAVAAKLTDSKLFADADAAAELVTGGQSGAVLGALPAQSRAAAQRVVEDAYAAGLDRVFLLGGLVAVVAGALVLLLVRGAATPAPGGDRPGAPGVKASEEGVPAV	MQKKWLILTIIVLIYLPVTIDATVMHVATPSLSAALNLTANQLLWIIDIYSLIMAGLILPMGALGDRIGFKKLLFIGTAVFGVGSLAAAFSPTAYALIASRAILGLGAAMLIPATLSGIRNAFTEEKQRNFALGIWSTVGGGGAAFGPLVGGFVLEHFHWGAVFLINIPIILAVLVMIVMIIPKQQEKTDQPINLGQALVLVVAILSLIYSIKSAMYNFSVLTVVMFVVGISTLIHFIRSQKRATTPMIDLELFKHPVISTSIVMAVVSMIALVGFELLLSQELQFVHGFSPLQAAMFIIPFMIAISLGGPLAGICLNKWGLRRVSSLGILVSALSLWGLAQLNFSTDHFLAWTCMVFLGFSIEIALLASTAAIMSSVPPQKASAAGAIEGMAYELGAGLGVAIFGLMLSWFYSRSIILPAELPSNLIEKASISIGETMQLASNLENPLGGQLIVVAQQAFSYAHSWVLTLSAICFFLLTVFVWFSFPKKVN	104.67	gnl|BL_ORD_ID|2718|hsp_num:0	3280			6	1230	erythromycin; acriflavine
BGC0001213.1|Nataxazole_31 # 36358 # 39228 # 1 # ID=1_31;partial=01;start_type=GTG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.729	BGC0001213.1|Nataxazole_31 	36358	39228	+	Loose	1100	30.8018	salA	25.81	3003749	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	sal-type ABC-F protein	GTGAACTCTTCGCAGGAATCCGACCTCGACCGTCGGCTCGCCCGGGAACCCATCGCCATCGTCGGCCTCTCCGCGCTCTTCCCCAAGTCCAGCAATCTGCGGGAGTTCTGGTCGAACGTCGTCTCGGCCGCCGACTGCATCGACGACGTGCCCGCCGACCACTGGGACGTCGACGAGCACTACGACCCGGACCCGACCGTGCCGGACAAGACGTACGCCCGGCGCGGCGGCTTCATCCCGGACACACCGTTCAACCCGCTGGAGTTCGGGCTGCCGCCCAACACGCTGGAGGTCACCGACGTCCTCCAGCTGCTCAGCCTGGTGGTCGCCCGCGACCTGCTGAAGGACGCCGGAGCCGACCAGGGCTGGTACGACAAGGCGCGCACCGGGGTCGTACTCGGCATCACCGGCGCCAACCAGCTCACCCAGCCGCTCACCGCCCGCCTCCAGAGCGGGGTGCTCAAGGAGGTCGTGCGCAGCTGCGGCCTGTCCCAGCGGGACGCCGAGGAGATCGTCGCCAAGTTCCGCCTGGCGTACGCCCCGTGGGAGGAGAACTCCTTCCCCGGCATGCTCGGCAACGTCGTCGCGGGACGCATCGCCAACCGGCTCGACCTCGGCGGCATCAACATGACGATCGACGCCGCCTGCGCCAGCTCCCTGGGCGCCGTCCGCTCCGCGGTCAGCGAACTGGTCGAGCGGCGCGCCGACACCATGCTCGTCGGCGGCTGCGACGCCGAGAACACGATCTTCATGTACCTGTGCTTCAGCAAGACCCCGGCGCTGTCGAAGTCCGGGAACATCCGCCCGTTCGACAAGAACGCCGACGGCACCCTCATCGGCGAGGGCATCGGCATGCTCGCGCTGCGCCGCCTCTCCGACGCCGAGCGCGACGGCAACAAGATCTACGCCGTGCTGCGCGGCATCGGCACCTCCAGCGACGGCCGCTTCAAGTCGATCTACGCCCCCCGCAAGGAGGGCCAGATGGTCGCGCTGCGCCGCGCCTACGAGGACGCCGACTGCTCGCCGTCCAGCATCGAGCTGTTCGAGGCGCACGGCACCGGCACCGCCGTCGGCGACGCCACCGAGCTGAGCGCGCTGTCCGCGGTCGTCTCCGAGTCCACCGAGGACCGCCGCTACGCGGCCCTGGGCAGCATCAAGTCGCAGATCGGGCACACCAAGGCGGCGGCCGGCGCGGCCGGCATGATCAAGCTGTCGCTCGCCCTGCACCACAAGGTGCTGCCGCCCACCATCAACGTGGACGAGCCCAACCCGGCCATCGACTTCACCTCGGGCCCGGTCTACGTCAACACCGAGGCCCGGCCCTGGATCCGCACCCCGGAGCGGCCCAAGCGCCGCGCCGCGCTCTCCTCGTTCGGCTTCGGCGGCACCAACTTCCACGTGGTCATGGAGGAGTACGGCGACGGCGACGACCTGCGCGTCTCCTACCCGGTCGCGGCCGTGCACCTGTGGCACGCGCCCGACACCGCGCAGCTCACCGAGGCGCTGGCCTCCGGCGCGCCCGCCACCGGCGGCCCGGCCCCCGAGGGCCACGCCCGCGTCGCGTTCGTCGCCCGCACCGCCGGAGAACTGGCCGACCTGCGCGCCCTCGCCCTCGGCGAACTGCGCGCCCGCCCCGACGCCGACACCTGGTCCCACCCCAAGGGCGTGTACTTCCGCCGCTCGGCCGCCGCCCAGGGCAAGGTCGCCGCGCTCTTCGCCGGACAGGGCAGCCAGTACGTCAACCCCGGCCGGACCGCCGTGATGGCGCTGCCGCCGCTGCGCGCCGCCTTCGACGCCGCCAACCACCACTTCGAGGGCGCCGAGCCGCTGTCCCGCGTCGCCTTCCCGCCGCCCGCCTTCGGCGAGGAGGAGCGCGCCGCGCAGGAGAGCGCGCTGCGGGCCACCGCGTACGCCCAGCCGGCCATCGGCGCGCTGTCCGCCGGGCAGTTCACCTACCTCAGCGAACTCGGCTTCCGCGCCGAGGGCTTCCTCGGCCACAGCTTCGGCGAGCTGACCGCGCTGTGGGCCGCGGGCGCCCTCACCGACGAGGCGTTCCACGCGCTGGCCCGCGCCCGCGGCAGGGCGATGGCCCCGCCCGCCGACGCCGGCACCGGTGCCGACACCGGCGCCATGGCCGCCCTGTCCGTCTCCGAGGCGCAGGTCACCGAACTCATCGCCGGACGCGACGGCGTGGTGGTCTGCAACCGCAACGCCCCGGACCAGATCGTCGTCGGCGGCCCCACCGCCGAGATCGACCGCCTCGTCGCCGACGCCCGCGACGCCGGACTGCGTGCCAGCAGGCTGCCCGTCTCCGCCGCCTTCCACACCCCCTTCGTCGGCCACGCCCTGGACGCCTTCCGCGCCGACCTGGAGCGCTACGAGGTGACCGCGCCCGAGGGCACGGTCCTCGCCGACACCGCGGGCGCCGCGTACGGCGACGACATCGCCGCCAACCGCGCGGTCCTCGCCGAACAGCTCATCAACCCGGTGGACTTCGCCACCCGCGTCGAGGAGCTGTACGAGGCCGGGCACCGGGTGTTCGTGGAGTTCGGGCCCAAGAACGTGCTCACCCAGCTCGTACGGCGCATCCTCGGCGACCGCGAGCACACCGCCATCGCCCTGGACGCCGGACCCGGCCGCGACGCGGACGTCGCCCTCAAGCAGGCCGTCGCCCAGCTCGCCGTGCACGGACTGCCCCTCGCGACGGCCGACCGCTATGTCGAGCCGGAGGCCGAGCAGGCCCCCGCCAAGGGCATGTCCATCCTGCTCAACGGCATCAACTACGTCTCGCCGGAGCGGAAGGCGAAGTACCGGGACGCCATCGAGAACGGCTACCGGATCGCCGTACCGACCCTGCCCGGTACCGCCGTG	MNSSQESDLDRRLAREPIAIVGLSALFPKSSNLREFWSNVVSAADCIDDVPADHWDVDEHYDPDPTVPDKTYARRGGFIPDTPFNPLEFGLPPNTLEVTDVLQLLSLVVARDLLKDAGADQGWYDKARTGVVLGITGANQLTQPLTARLQSGVLKEVVRSCGLSQRDAEEIVAKFRLAYAPWEENSFPGMLGNVVAGRIANRLDLGGINMTIDAACASSLGAVRSAVSELVERRADTMLVGGCDAENTIFMYLCFSKTPALSKSGNIRPFDKNADGTLIGEGIGMLALRRLSDAERDGNKIYAVLRGIGTSSDGRFKSIYAPRKEGQMVALRRAYEDADCSPSSIELFEAHGTGTAVGDATELSALSAVVSESTEDRRYAALGSIKSQIGHTKAAAGAAGMIKLSLALHHKVLPPTINVDEPNPAIDFTSGPVYVNTEARPWIRTPERPKRRAALSSFGFGGTNFHVVMEEYGDGDDLRVSYPVAAVHLWHAPDTAQLTEALASGAPATGGPAPEGHARVAFVARTAGELADLRALALGELRARPDADTWSHPKGVYFRRSAAAQGKVAALFAGQGSQYVNPGRTAVMALPPLRAAFDAANHHFEGAEPLSRVAFPPPAFGEEERAAQESALRATAYAQPAIGALSAGQFTYLSELGFRAEGFLGHSFGELTALWAAGALTDEAFHALARARGRAMAPPADAGTGADTGAMAALSVSEAQVTELIAGRDGVVVCNRNAPDQIVVGGPTAEIDRLVADARDAGLRASRLPVSAAFHTPFVGHALDAFRADLERYEVTAPEGTVLADTAGAAYGDDIAANRAVLAEQLINPVDFATRVEELYEAGHRVFVEFGPKNVLTQLVRRILGDREHTAIALDAGPGRDADVALKQAVAQLAVHGLPLATADRYVEPEAEQAPAKGMSILLNGINYVSPERKAKYRDAIENGYRIAVPTLPGTAV	MLFLFEEKALEVEHKVLIPELTFSIEDHEHLAIVGVNGVGKSTLLKVIHQDQSVDSAMMEQDLTPYYDWTVMDYIIESYPEIAKIRLQLNHTDMINKYIELDGYIIEGEIVTEAKKLGIKEEQLEQKISTLSGGEQTKVSFLKVKMSKASLLLIDEPTNHMDLEMKEWLTKAFKQEQRAILFVSHDRTFLNETPDAILELSLDGAKKYIGKYDKYKQQKDIEHETLKLQYEKQQKEQAAIEETIKKYKAWYQKAEQSASVRSPYQQKQLSKLAKRFKSKEQQLNRKLDQEHIPNPHKKEKTFSIQHHNFKSHYLVQFNHVSFAYDNRKIFDDVSFYIKRNQNVIVEGRNGTGKSTLIKLILGELEPTKGDITVHPELEIGYFSQDFENLNMHHTVLDEILEIPEMKEADARTILASFYFDKDRINDVVETLSMGEKCRLQFVKLYFSNPHIMILDEPTNYFDIGMQENIIQLIQSFQGSVLIVSHDNYFKSQIKDQTWTIKNHQMTHENVQVKDPINTESMKHHLKELEQYTDERNRETEF	176.89	gnl|BL_ORD_ID|2051|hsp_num:0	2265			1356	1620	lincomycin; clindamycin; virginiamycin M1; tiamulin; retapamulin
